Skip to main content
Clinical Trials/NCT02884440
NCT02884440CompletedPhase 2

Transverse Abdominis Plane Block for Anterior Approach Spine Surgery: A Prospective Randomized Study

Rennes University Hospital1 site in 1 country43 target enrollmentStarted: November 7, 2016Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
43
Locations
1
Primary Endpoint
Morphine consumption in the first 24 hours after spine surgery by anterior approach

Study Overview

Brief Summary

Therapeutic, prospective, randomized, double blind, placebo-controlled, in intention to treat, monocentric study to evaluate the analgesic efficacy of a bilateral TAP block after spine surgery with 24 hours morphine consumption

Detailed Description

ALIF is a commonly performed procedure for the treatment of degenerative diseases of the lumbar spine or spondylolisthesis. This technique has many advantages attributed to the absence of posterior spinal muscular pain, a more direct visualization of the disk space, lower incidence of neurological injuries... However, patients experienced moderate to high post operative parietal abdominal pain due to this specific anterior approach. The systematic need for opioids administration may cause many complications and delay the post operative recovery time. The TAP block has been described as an effective pain control technique after various lower abdominal surgeries, reducing both pain scores and 24 hours opioids consumption. However the analgesic efficacy of this technique on specific parietal abdominal pain experienced after spine surgery by anterior approach is not clear

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patient with age above 18 years old
  • Patients scheduled for spine surgery by anterior approach
  • Patient who signed an informed consent form

Exclusion Criteria

  • Allergy to ropivacaine
  • Weight < 50 kg
  • Contra indication to TAP block : sepsis in the point of draining, bleeding disorder
  • Contra indication to paracetamol: severe hepatic insufficiency
  • Contra indication to ketoprofen: age ≥ 75 years, renal insufficiency, previous gastric ulcer, allergy
  • Contra indication to nefopam: severe cardiac insufficiency, glaucoma, prostate hypertrophy, allergy
  • Known allergy to active substance or at least to one excipient (propofol, paracetamol, morphine, remifentanil, cisatracurium)
  • Allergy to fentanyl, atracurium, or benzin sulfonic acid derivative, to propacetamol
  • Convulsions or previous convulsive disorder
  • Severe respiratory insufficiency
  • Abnormal hemostasis or anticoagulant treatment because of possible intramuscular injection
  • Morphine intake 24 hours before surgery
  • Chronic use of morphine, gabapentin, pregabalin
  • Pregnancy or breastfeeding
  • Patient unable to use Patient Controlled Analgesia (PCA) (old patient depends...)
  • Patients subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty

Arms & Interventions

TAP block ropivacaine

Experimental

Bilateral ultrasound guided with 15 ml ropivacaine 5mg/ml on each side under general anesthesia at the end of the intervention

Intervention: TAP block ropivacaine (Drug)

TAP block ropivacaine

Experimental

Bilateral ultrasound guided with 15 ml ropivacaine 5mg/ml on each side under general anesthesia at the end of the intervention

Intervention: General anesthesia (Drug)

TAP block placebo

Placebo Comparator

Bilateral ultrasound guided with 15 ml saline on each side under general anesthesia at the end of the intervention

Intervention: TAP block placebo (Drug)

TAP block placebo

Placebo Comparator

Bilateral ultrasound guided with 15 ml saline on each side under general anesthesia at the end of the intervention

Intervention: General anesthesia (Drug)

Outcomes

Primary Outcomes

Morphine consumption in the first 24 hours after spine surgery by anterior approach

Time Frame: 24 hours

Secondary Outcomes

  • Morphine consumption in the first 48 hours after spine surgery by anterior approach(48 hours)
  • Delay before the first lift(Day 1)
  • Assessment of pain(1, 6, 12, 24 and 48 hours)
  • Assessment of post operative nausea or vomiting(48 hours)
  • Delay before first morphine administration(Day 1)
  • Delay before resumption of transit(Day 1)
  • Duration of hospitalization(Day 1)
  • Patient satisfaction(48 hours)

Investigators

Sponsor
Rennes University Hospital
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Transverse Abdominis Plane Block for... | Clinical Trial